Drug intelligence / Profile preview

dongtian changchun ointment

Development stage: Unknown
Lead developer: Shanghai Leiyunshang Pharmaceutical
Administration: Oral

Overview

Dongtian Changchun Ointment is a Traditional Chinese Medicine (TCM) herbal paste (Gao Fang) developed by Zhongshan Hospital and Shuguang Hospital in Shanghai for the management of stable chronic obstructive pulmonary disease (COPD). It is traditionally administered orally during the winter months to strengthen the body's constitution and prevent respiratory flare-ups. In clinical research, it is evaluated as an adjuvant therapy alongside standard treatments like budesonide and formoterol to reduce the frequency of acute exacerbations and improve clinical symptoms and lung function.

Brand names: Dong-Tian Chang-Chun Ointment
Other names: Dong-Tian Chang-Chun Ointment

Beyond the preview

Go deeper on dongtian changchun ointment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on dongtian changchun ointment.

Explore the full profile